Statistics for Leveraging copper chelators as targeted therapy for BRAFV600E mutant thyroid cancer
Total visits
| views | |
|---|---|
| Leveraging copper chelators as targeted therapy for BRAFV600E mutant thyroid cancer | 110 |
Total visits per month
| views | |
|---|---|
| July 2024 | 1 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
File Visits
| views | |
|---|---|
| Xu_duke_0066D_14732.pdf | 165 |
Top country views
| views | |
|---|---|
| United States | 7 |
| Germany | 5 |
| China | 3 |
| France | 1 |
| United Kingdom | 1 |
Top city views
| views | |
|---|---|
| Beijing | 2 |
| Saint Paul | 2 |
| Ashburn | 1 |
| Chaoyang | 1 |
| Durham | 1 |
| Houston | 1 |
| Pfafftown | 1 |
| Yulee | 1 |